0QCV: Arrowstreet Capital Ltd: Form 8.3 - Abbvie Inc

  0QCV: Arrowstreet Capital Ltd: Form 8.3 - Abbvie Inc  UK Regulatory Announcement  LONDON                                                                        FORM 8.3             PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY      A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE                    Rule 8.3 of the Takeover Code (the “Code”)  1. KEY INFORMATION  (a) Identity of the person whose positions/dealings     Arrowstreet Capital, are being disclosed:                                     Limited Partnership (b) Owner or controller of interests and short positions disclosed, if different from 1(a):                                                           The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to whose relevant securities this form relates:                   AbbVie Inc  Use a separate form for each offeror/offeree (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of       offeror/offeree: (e) Date position held/dealing undertaken:               22/07/2014 (f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of      YES any other party to this offer?  2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE  (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)  Class of relevant           Common shares of USD 0.01 par value US00287Y1091 security:                             Interests                    Short positions                              Number           %           Number        % (1) Relevant securities      5,362,225         0.34%                      owned and/or controlled: (2) Derivatives (other                                                  than options): (3) Options and agreements                                              to purchase/sell: TOTAL:                       5,362,225         0.34%                       All interests and all short positions should be disclosed.  Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).  (b) Rights to subscribe for new securities (including directors’ and other executive options)  Class of relevant security in relation to which subscription right exists:   Details, including nature of the rights concerned and relevant percentages:   If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.  3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE  (a) Purchases and sales  Class of relevant security        Purchase/sale  Number of    Price per                                                    securities    unit Common shares of USD 0.01 par      Purchase        126,083       54.1042 USD value US00287Y1091  (b) Derivatives transactions (other than options)                             Nature of dealing Class of    Product                                       Number of     Price relevant   description   e.g. opening/closing a        reference    per security                   long/short position,           securities    unit             e.g. CFD       increasing/reducing a                            long/short position  (c) Options transactions in respect of existing securities  (i) Writing, selling, purchasing or varying                           Writing,      Number of               Type                 Option Class of   Product       purchasing,   securities   Exercise                        money relevant  description  selling,     to which    price     e.g.       Expiry  paid/ security   e.g. call     varying       option       per unit   American,   date     received            option        etc.          relates                 European             per unit                                                                etc.  (ii) Exercising  Class of relevant          Product description   Number of     Exercise price security                                       securities   per unit                            e.g. call option  (d) Other dealings (including subscribing for new securities)                      Nature of dealing Class of relevant                      Details  Price per unit (if security            e.g. subscription,             applicable)                     conversion  The currency of all prices and other monetary amounts should be stated.  Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.  4. OTHER INFORMATION  (a) Indemnity and other dealing arrangements  Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:  If there are no such agreements, arrangements or understandings, state “none” None  (b) Agreements, arrangements or understandings relating to options or derivatives  Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:  (i) the voting rights of any relevant securities under any option; or  (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:  If there are no such agreements, arrangements or understandings, state “none” None  (c) Attachments  Is a Supplemental Form 8 (Open Positions) attached?  NO  Date of disclosure:  23/07/2014 Contact name:         Jeffrey Morandi Telephone number:     +1 (617) 919-0136  Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.  The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.  Contact:  Arrowstreet Capital Ltd  
Press spacebar to pause and continue. Press esc to stop.